美东时间1月14日周二,美国制药巨头礼来发布了2024年全年业绩预期及2025年业绩指引。公司预计2024年第四季度营收约为135亿美元,同比增长45%;全年营收约450亿美元,同比增长32%。但这分别低于预期的140亿美元以及455亿美元。公司解释称减肥药需求增长低于预期,影响了业绩。下调业绩预期股价大跌根据公司公告,礼来预计2024年营收将达到约450亿美元,同比增长32%,这低于该公司10...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.